For patients with metastatic disease, SDHB should be tested first as more than 40% of this mutation is related to metastatic PCC/PGL and 5.5% of PCC/PGL patients carried SDHB germline mutation (27, 40). This evidence concerns the gene SDHB and adrenal gland pheochromocytoma.